Literature DB >> 29283065

We are not Alone in Our Body: Insights into the Involvement of Microbiota in the Etiopathogenesis and Pharmacology of Mental Illness.

Claudia Pisanu1,2, Alessio Squassina1,3.   

Abstract

BACKGROUND: The etiopathogenesis of psychiatric disorders is still not completely understood. Growing evidence supports the hypothesis that mental illness and related disturbances do not necessarily originate in the brain. Inflammation has been suggested to play a central role in psychiatric disorders and altered levels of peripheral cytokines have been reported in several studies. Recently, it has emerged that bacteria populating the human gut could modulate low-grade inflammation, as well as high-order brain functions, including mood and behavior. These bacteria constitute the microbiota, a large population comprising 40,000 bacterial species and 1,800 phila involved in key processes important to maintain body homeostasis.
METHOD: In this review, we present and discuss studies exploring the role of dysbiosis and products of the gutmicrobiota in the pathogenesis of psychiatric disorders, as well as their potential involvement in mediating the effect of antidepressants, mood stabilizers, and antipsychotics.
RESULTS: Although this field is still at its early stage of development, a growing number of studies suggest that an altered composition of the gut microbiota, together with translocation of bacterial products into the systemic circulation, might play a role in the pathogenesis of psychiatric disorders as well as in response to psychotropic medications.
CONCLUSION: An altered composition and functioning of gut microbiota have been reported in psychiatric disorders, and recent findings suggest that gut bacteria could be involved in modulating the efficacy of psychotropic medications. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Microbiota; antidepressants; antipsychotics; bipolar disorder; gut-brain axis; major depressive disorder; microbiome; mood stabilizers.

Mesh:

Substances:

Year:  2018        PMID: 29283065     DOI: 10.2174/1389200219666171227204144

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  4 in total

1.  Investigating the relationship between melatonin levels, melatonin system, microbiota composition and bipolar disorder psychopathology across the different phases of the disease.

Authors:  Mirko Manchia; Alessio Squassina; Claudia Pisanu; Donatella Congiu; Mario Garzilli; Beatrice Guiso; Federico Suprani; Pasquale Paribello; Vittoria Pulcinelli; Maria Novella Iaselli; Federica Pinna; Flavia Valtorta; Bernardo Carpiniello; Stefano Comai
Journal:  Int J Bipolar Disord       Date:  2019-12-09

2.  Mental awareness improved mild cognitive impairment and modulated gut microbiome.

Authors:  Wei Wei Thwe Khine; Miao Lian Voong; Ted Kheng Siang Ng; Lei Feng; Grishma Avinash Rane; Alan Prem Kumar; Ee Heok Kua; Ratha Mahendran; Rathi Mahendran; Yuan-Kun Lee
Journal:  Aging (Albany NY)       Date:  2020-12-09       Impact factor: 5.682

3.  Gut microbiome: A potential indicator for predicting treatment outcomes in major depressive disorder.

Authors:  Zaiquan Dong; Xiaoling Shen; Yanni Hao; Jin Li; Haizhen Xu; Li Yin; Weihong Kuang
Journal:  Front Neurosci       Date:  2022-07-22       Impact factor: 5.152

4.  Antidepressant Effects of Rosemary Extracts Associate With Anti-inflammatory Effect and Rebalance of Gut Microbiota.

Authors:  Ying Guo; Jianping Xie; Xia Li; Yun Yuan; Lanchun Zhang; Weiyan Hu; Haiyun Luo; Haofei Yu; Rongping Zhang
Journal:  Front Pharmacol       Date:  2018-10-02       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.